Genoa, Italy-The use of alcohol ablation of the prostate to treat patients with symptomatic bladder outlet obstruction secondary to BPH yielded promising results in a number of studies presented at the World Congress on Endourology here. Researchers reported on the use of two forms of alcohol ablation-one using an anhydrous alcohol solution and one using a viscous gel. Both technologies are considered investigative.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.